日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Ropeginterferon Alfa-2b: Efficacy and Safety in Different Age Groups

罗培干扰素α-2b:不同年龄组的疗效和安全性

Gisslinger, Heinz; Klade, Christoph; Georgiev, Pencho; Krochmalczyk, Dorota; Gercheva-Kyuchukova, Liana; Egyed, Miklos; Rossiev, Viktor; Dulicek, Petr; Illes, Arpad; Pylypenko, Halyna; Sivcheva, Lylia; Mayer, Jiri; Yablokova, Vera; Krejcy, Kurt; Hasselbalch, Hans C; Kralovics, Robert; Kiladjian, Jean-Jacques

Safety of bosutinib versus imatinib in the phase 3 BELA trial in newly diagnosed chronic phase chronic myeloid leukemia

在 BELA 3 期试验中,博舒替尼与伊马替尼在初诊慢性期慢性粒细胞白血病患者中的安全性比较

Gambacorti-Passerini, Carlo; Cortes, Jorge E; Lipton, Jeff H; Dmoszynska, Anna; Wong, Raymond S; Rossiev, Victor; Pavlov, Dmitri; Gogat Marchant, Karin; Duvillié, Ladan; Khattry, Navin; Kantarjian, Hagop M; Brümmendorf, Tim H